.Enterprise Value (EV)
Difficulty: Intermediate
Current Enterprise Value (EV)
Biogen Inc., current enterprise value calculation
| Current share price (P) | $ |
| No. shares of common stock outstanding | |
| USD $ in thousands | |
| Common equity (market value) | |
| Add: Preferred stock, par value $0.001 per share (per books) | |
| Add: Noncontrolling interests (per books) | |
| Total equity | |
| Add: Current portion of notes payable and other financing arrangements (per books) | |
| Add: Notes payable and other financing arrangements, excluding current portion (per books) | |
| Total equity and debt | |
| Less: Cash and cash equivalents | |
| Less: Marketable securities | |
| Enterprise value (EV) | |
Historical Enterprise Value (EV)
Biogen Inc., EV calculation
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| No. shares of common stock outstanding1 | ||||||
| Share price1, 2 (USD $) | ||||||
| USD $ in thousands | ||||||
| | Common equity (market value) | |||||
| | Add: Preferred stock, par value $0.001 per share (per books) | |||||
| | Add: Noncontrolling interests (per books) | |||||
| | Total equity | |||||
| | Add: Current portion of notes payable and other financing arrangements (per books) | |||||
| | Add: Notes payable and other financing arrangements, excluding current portion (per books) | |||||
| | Total equity and debt | |||||
| | Less: Cash and cash equivalents | |||||
| | Less: Marketable securities | |||||
| | Enterprise value (EV) | |||||
2 Close price on the filing date of Biogen Inc.'s Annual Report.
| Item | Description | The company |
|---|---|---|
| EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Biogen Inc.'s EV declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level. |
